Hydrocortisone enhances the function of the blood-nerve barrier through the up-regulation of claudin-5

Neurochemical Research

Volumn 36, Issue 5, 2011, Pages 849-855

  Kashiwamura, Yoko ^a   Sano, Yasuteru ^a   Abe, Masaaki ^a   Shimizu, Fumitaka ^a   Haruki, Hiroyo ^a   Maeda, Toshihiko ^a   Kawai, Motoharu ^a   Kanda, Takashi ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood nerve barrier; Claudin 5; Glucocorticoid; Peripheral nerve microvascular endothelial cells; Tight junction

Indexed keywords

CLAUDIN 5; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE;

ARTICLE; BLOOD NERVE BARRIER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROVASCULAR ENDOTHELIAL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

BASE SEQUENCE; BLOOD-NERVE BARRIER; BLOTTING, WESTERN; CELL LINE, TRANSFORMED; DNA PRIMERS; ENDOTHELIUM, VASCULAR; HUMANS; HYDROCORTISONE; LIGANDS; MEMBRANE PROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIGHT JUNCTIONS; UP-REGULATION;

EID: 79954440817     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-011-0413-6     Document Type: Article

References (26)

1. JF Poduslo GL Curran CT Berg 1994 Macromolecular permeability across the blood-nerve and blood-brain barriers Proc Natl Acad Sci USA 91 5705 5709 8202551 10.1073/pnas.91.12.5705 1:CAS:528:DyaK2cXksFCntLc%3D (Pubitemid 24174397)
2. MA Bell AGM Weddell 1984 A descriptive study of the blood vessels of the sciatic nerve in the rat, man, and other mammals Brain 107 871 898 6478181 10.1093/brain/107.3.871 (Pubitemid 14036975)
3. CH Latker KC Wadhwani A Balbo SI Rapoport 1991 Blood-nerve barrier in the frog during Wallerian degeneration: Are axons necessary for maintenance of barrier functions? J Comp Neurol 309 650 664 10.1002/cne.903080410
4. Y Sano F Shimizu H Nakayama, et al. 2007 Endothelial cells constituting blood-nerve barrier have highly specialized characteristics as barrier-forming cells Cell Struct Funct 32 139 147 18057801 10.1247/csf.07015 1:CAS:528:DC%2BD1cXhtVKms7fI (Pubitemid 351483586)
5. T Kanda M Yamawaki T Iwasaki, et al. 2000 Glycosphingolipid antibodies and blood-nerve barrier in autoimmune demyelinative neuropathy Neurology 54 1459 1464 10751258 1:CAS:528:DC%2BD3cXivFOitb8%3D (Pubitemid 30210466)
6. T Kanda Y Numata H Mizusawa 2004 Chronic inflammatory demyelinating polyneuropathy: decreased claudin-5 and relocated ZO-1 J Neurol Neurosurg Psychiatry 75 765 769 15090575 10.1136/jnnp.2003.025692 1:STN:280: DC%2BD2c7pslCrug%3D%3D (Pubitemid 38526691)
7. B Lach P Rippstein D Atack, et al. 1993 Immunoelectron microscopic localization of monoclonal IgM antibodies in gammopathy associated with peripheral demyelinative neuropathy Acta Neuropathol 85 298 307 8384775 10.1007/BF00227726 1:STN:280:DyaK3s3ht1KjtQ%3D%3D (Pubitemid 23081179)
8. PJ Dyck PC O'Brien KF Oviatt, et al. 1982 Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment Ann Neurol 11 136 141 7041788 10.1002/ana.410110205 1:STN:280:DyaL387otV2ltQ%3D%3D (Pubitemid 12162978)
9. R Hughes S Bensa H Willison, et al. 2001 Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy Ann Neurol 50 195 201 11506402 10.1002/ana.1088 1:CAS:528:DC%2BD3MXmsVOksbg%3D (Pubitemid 32738144)
10. DH Miller AJ Thompson SP Morrissey, et al. 1992 High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect J Neurol Neurosurg Psychiatry 55 450 453 1619410 10.1136/jnnp.55.6.450 1:STN:280:DyaK38zhsl2huw%3D%3D
11. J Schmidt JM Metselaar MH Wauben, et al. 2003 Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis Brain 126 1895 1904 12805101 10.1093/brain/awg176 (Pubitemid 36917348)
12. C Förster C Silwedel N Golenhofen, et al. 2005 Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system J Physiol 565 475 486 15790664 10.1113/jphysiol. 2005.084038 (Pubitemid 40879596)
13. C Förster M Burek IA Romero, et al. 2008 Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier J Physiol 586 1937 1949 18258663 10.1113/jphysiol.2007.146852 (Pubitemid 351997519)
14. T Kanda T Iwasaki M Yamawaki, et al. 1997 Isolation and culture of bovine endothelial cells of endoneurial origin J Neurosci Res 49 769 777 9335264 10.1002/(SICI)1097-4547(19970915)49:6<769::AID-JNR11>3.0.CO;2-N 1:CAS:528:DyaK2sXmtl2gtLo%3D (Pubitemid 27430176)
15. M Furuse T Hirase M Itoh, et al. 1993 Occludin: A novel integral membrane protein localizing at tight junctions J Cell Biol 123 1777 1788 8276896 10.1083/jcb.123.6.1777 1:CAS:528:DyaK2cXisFynsQ%3D%3D (Pubitemid 24012933)
16. T Nitta M Hata S Gotoh, et al. 2003 Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice J Cell Biol 161 653 660 12743111 10.1083/jcb.200302070 1:CAS:528:DC%2BD3sXjvVeqsb8%3D (Pubitemid 36578587)
17. BT Hawkins TP Davis 2005 The blood-brain barrier/neurovascular unit in health and disease Phamacol Rev 57 173 185 1:CAS:528:DC%2BD2MXlsFejtL0%3D (Pubitemid 41043883)
18. T Hirase JM Staddon M Saitou 1997 Occludin as a possible determinant of tight junction permeability in endothelial cells J Cell Sci 110 1603 1613 9247194 1:CAS:528:DyaK2sXkvFCisrc%3D (Pubitemid 27338748)
19. S Ohtsuki H Yamaguchi Y Katsukura, et al. 2008 mRNA expression levels of tight junction protein genes in mouse brain capillary endothelial cells highly purified by magnetic cell sorting J Neurochem 104 147 154 17971126 1:CAS:528:DC%2BD1cXhtFehsbo%3D (Pubitemid 350265064)
20. S Ohtsuki S Sato H Yamaguchi, et al. 2007 Exogenous expression of claudin-5 induces barrier properties in cultured rat brain capillary endothelial cells J Cell Physiol 210 81 86 16998798 10.1002/jcp.20823 1:CAS:528: DC%2BD28XhtlWktrjP (Pubitemid 44904703)
21. T Kanda S Usui H Beppu, et al. 1998 Blood-nerve barrier in IgM paraproteinemic neuropathy: a clinicopathologic assessment Acta Neuropathol 95 184 192 9498055 10.1007/s004010050785 1:CAS:528:DyaK1cXjslygug%3D%3D (Pubitemid 28076015)
22. C Meier K Roberts A Steck, et al. 1984 Polyneuropathy in Waldenström's macroglobulinaemia: reduction of endoneurial IgM-deposits after treatment with chlorambucil and plasmapheresis Acta Neuropathol 64 297 307 6095580 10.1007/BF00690395 1:STN:280:DyaL2M%2FmvVKitg%3D%3D (Pubitemid 14004751)
23. H Köller BC Kieseier S Jander, et al. 2005 Chronic inflammatory demyelinating polyneuropathy N Engl J Med 352 1343 1356 15800230 10.1056/NEJMra041347 (Pubitemid 40411501)
24. JM Vallat C Sommer L Magy 2010 Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition Lancet Neurol 9 402 412 20298964 10.1016/S1474-4422(10)70041-7
25. JP Tuckermann A Kleiman KG McPherson, et al. 2005 Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis Crit Rev Clin Lab Sci 42 71 104 15697171 10.1080/10408360590888983 1:CAS:528:DC%2BD2cXhtFSnsbrK (Pubitemid 41656710)
26. MD Heitzer IM Wolf ER Sanchez, et al. 2007 Glucocorticoid receptor physiology Rev Endocr Metab Disord 8 321 330 18049904 10.1007/s11154-007-9059-8 1:CAS:528:DC%2BD1cXktVyjtQ%3D%3D